Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00007007 · ClinicalTrials.gov registry record · NA
Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases
A NA study of Metastatic Cancer and Radiation Toxicity, sponsored by Radiation Therapy Oncology Group.
- Completed
- Registry status
- NA
- Development phase
- 59
- Enrollment target
- 20
- Study locations
NCT00007007: Completed NA study of Metastatic Cancer and Radiation Toxicity, sponsored by Radiation Therapy Oncology Group.
NCT00007007 is a NA study of Metastatic Cancer and Radiation Toxicity that has completed, run by Radiation Therapy Oncology Group. The registered enrollment target is 59 participants, below the 443-participant average among 109 other Metastatic Cancer trials with a reported enrollment target (87% lower). The trial reports 20 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00007007, a NA study of Metastatic Cancer and Radiation Toxicity, has completed, sponsored by Radiation Therapy Oncology Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
- 20
- Study locations
Study Summary
RATIONALE: Assessment of patients undergoing radiation therapy may help to determine the effects of the treatment and may help improve cancer treatment. PURPOSE: This clinical trial is studying the memory skills in patients receiving radiation therapy for brain metastases.
Conditions Studied
Interventions
- PROCEDURE quality-of-life assessment
- PROCEDURE management of therapy complications
Study Locations (20)
California
- Mount Diablo Medical Center - Concord
- Cancer Center and Beckman Research Institute, City of Hope - Duarte
- California Cancer Center - Fresno
- Saint Agnes Cancer Center - Fresno
- Glendale Memorial Hospital and Health Center - Glendale
- Sutter Health Western Division Cancer Research Group - Greenbrae
- University of California San Diego Cancer Center - La Jolla
- Loma Linda University Medical Center - Loma Linda
- Veterans Affairs Medical Center - Long Beach - Long Beach
- USC/Norris Comprehensive Cancer Center and Hospital - Los Angeles
- Jonsson Comprehensive Cancer Center, UCLA - Los Angeles
Alabama
- University of Alabama at Birmingham Comprehensive Cancer Center - Birmingham
- Huntsville Hospital System - Huntsville
- Comprehensive Cancer Institute of Huntsville - Huntsville
- MBCCOP - Gulf Coast - Mobile
- Alabama Oncology, LLC - Montgomery
- Radiation Oncology Associates of West Alabama - Tuscaloosa
Arizona
- Foundation for Cancer Research and Education - Phoenix
- Arizona Cancer Center - Tucson
Alaska
- Providence Alaska Medical Center - Anchorage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2000-11 |
| Est. Completion | 2004-12 |
| Phase | NA |
What the finished NCT00007007 record still lists
NCT00007007 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 59 participants, a relatively small participant target, below the 443-participant average among 109 other Metastatic Cancer trials with a reported enrollment target (87% lower).
The record links to 3 conditions, with Metastatic Cancer appearing as the primary indexed condition, and to 2 interventions - of which quality-of-life assessment is the first listed.
NCT00007007 names 20 study sites across 4 states, led by California, Alabama, Arizona.
Frequently Asked Questions
What is clinical trial NCT00007007 about?
NCT00007007 is a clinical study titled "Evaluation of Memory Skills in Patients Receiving Radiation Therapy for Brain Metastases". RATIONALE: Assessment of patients undergoing radiation therapy may help to determine the effects of the treatment and may help improve cancer treatment. PURPOSE: This clinical trial is studying the memory skills in patients receiving radiation therapy for brain metastases.
What is the current status of trial NCT00007007?
This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2000-11. Estimated completion is 2004-12.
What conditions does trial NCT00007007 study?
This clinical trial studies the following conditions: Metastatic Cancer, Radiation Toxicity, Cognitive/Functional Effects.
What interventions are being tested in trial NCT00007007?
The interventions under investigation include: quality-of-life assessment (PROCEDURE), management of therapy complications (PROCEDURE).
Who is sponsoring clinical trial NCT00007007?
This trial is sponsored by Radiation Therapy Oncology Group, which has 144 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00007007 being conducted?
This trial has 20 study locations across Alabama, Alaska, Arizona, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metastatic Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00007007's enrollment target sits among peer trials
59 52nd of 109 higher than 57 of 109 other Metastatic Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Metastatic Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer
RECRUITING · NA
-
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
RECRUITING · NA
-
A Study of the ApricityCare Program for Early Detection and Management of Treatment-Related Adverse Events in Patients With Cancer
RECRUITING · NA
-
Comparison of Whole Body DWI to FDG PET
RECRUITING · NA
-
Palliative Spatially Fractionated (GRID) Radiotherapy Using Intensity Modulated Proton Therapy
RECRUITING · NA
-
COBRA: Cancer, Older Adults, Balance and Resistance Activities
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia